Fig 1. Geographic variation in cervical cancer burden (A) and recurrent or metastatic cervical cancer burden (B) across the US for the period 2017–2022, and locations of brachytherapy centers as blue circles.

Cervical cancer burden was defined as the prevalent number of cervical cancer diagnoses per 100,000 eligible female enrollees. Recurrent or metastatic cervical cancer burden was defined as the proportion of patients with cervical cancer who initiated system therapy. Contains information from OpenStreetMap and OpenStreetMap Foundation, which is licensed under the Open Data Commons Open Database License (https://www.openstreetmap.org/copyright).